VML Revenue and Competitors

Location

N/A

Total Funding

Marketing

Industry

Estimated Revenue & Valuation

  • VML's estimated annual revenue is currently $404.6M per year.(i)
  • VML's estimated revenue per employee is $350,000

Employee Data

  • VML has 1156 Employees.(i)

VML's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Executive Director, Office Global CEO, VMLReveal Email/Phone
3
CEOReveal Email/Phone
4
Global CEO, VMLReveal Email/Phone
5
Executive Director, Office Global CEO, VMLReveal Email/Phone
6
Chief Operating OfficerReveal Email/Phone
7
CFOReveal Email/Phone
8
Chief Analytics & Data OfficerReveal Email/Phone
9
Global Chief Experience (CX) Strategy OfficerReveal Email/Phone
10
Chief Financial Officer, NAReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.2M31-6%N/AN/A
#2
$2.3M15N/AN/AN/A
#3
$6M3015%N/AN/A
#4
$9.8M494%N/AN/A
#5
$8.8M445%N/AN/A
#6
$1.1M9-25%N/AN/A
#7
$1.5M1011%N/AN/A
#8
$6.4M327%N/AN/A
#9
$124.1M397-1%N/AN/A
#10
$30.5M1226%N/AN/A
Add Company

What Is VML?

keywords:N/A

N/A

Total Funding

1156

Number of Employees

$404.6M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

VML News

2022-04-17 - EV parts maker Schaeffler signs first of a kind European rare earth ...

... 2019 and the new deal will enable the company to build a commercial separation facility, sourcing raw materials from Vital Metals (VML.

2022-04-06 - Turning Points: Cook and VMLY&R prove staying power (Video ...

VML CEO Jon Cook celebrates his 20th anniversary at the agency's Kansas City headquarters. Leslie Collins | KCBJ. Homegrown talent. Kansas City...

2022-03-30 - Neutrophil and natural killer cell imbalances prevent muscle stem ...

Following degenerative VML injuries, we observed the heightened infiltration of natural killer (NK) cells as well as the persistence of neutrophils beyond 2 wk...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$265M118336%N/A
#2
$894M120310%N/A
#3
$308.5M12819%N/A
#4
$75M12821%N/A
#5
$245M13184%N/A